Yüklüyor......
Benefits of introduction of Oncotype DX(®) testing
INTRODUCTION: Decisions regarding adjuvant chemotherapy in women with oestrogen receptor positive, human epidermal growth factor receptor 2 negative, node negative, early invasive breast cancer are unclear. The Recurrence Score(®) (RS) from Oncotype DX(®) (ODX) testing guides decisions based on indi...
Kaydedildi:
| Yayımlandı: | Ann R Coll Surg Engl |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Royal College of Surgeons
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6303812/ https://ncbi.nlm.nih.gov/pubmed/30322288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1308/rcsann.2018.0173 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|